Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongyi Zeng

Showing results (141-150 of 196) with videos related to

Pageof 20
Sort By:
Elife|September 13, 2024
Engineering PEG10assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccinationRuijing Tang, Luobin Guo, Tingyu Wei, et al.
Cancer Management and Research|May 23, 2019
The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resectionHongzhi Liu, Hui Chen, Xiaomo Wu, et al.
International Journal of Surgery (London, England)|April 16, 2024
Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection: a multicenter cohort studyLei Liu, Shangdong Qin, Kongying Lin, et al.
Proteomics. Clinical Applications|April 17, 2013
Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patientsYunbin Ye, Aimin Huang, Chuanzhong Huang, et al.
Frontiers in Oncology|March 8, 2021
Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular CarcinomaKongying Lin, Qizhen Huang, Lei Wang, et al.
ILIVER|July 10, 2025
Tumor burden score and alpha-fetoprotein level predict prognosis of patients with unresectable hepatocellular carcinoma treated with tyrosine kinase inhibitor and anti-PD-1 antibodyShichuan Tang, Tingfeng Huang, Cong Luo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2025
Preoperative risk stratification for multifocal intrahepatic cholangiocarcinoma after liver resection: a multicenter analysis with CART modelJun Fu, Qizhu Lin, Lifang Zheng, et al.
Journal for Immunotherapy of Cancer|May 23, 2020
Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case reportYongyi Zeng, Wei Zhang, Zhenli Li, et al.
Data in Brief|November 7, 2015
Dataset for the quantitative proteomics analysis of the primary hepatocellular carcinoma with single and multiple lesionsXiaohua Xing, Yao Huang, Sen Wang, et al.
Nanoscale|January 12, 2021
Localized NIR-II photo-immunotherapy through the combination of photothermal ablation and <i>in situ</i> generated interleukin-12 cytokine for efficiently eliminating primary and abscopal tumorsXinyi Lin, Xiaoyan Wang, Jiong Li, et al.
Pageof 20

Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
Elife|September 13, 2024
Engineering PEG10assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccinationRuijing Tang, Luobin Guo, Tingyu Wei, et al.
Cancer Management and Research|May 23, 2019
The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resectionHongzhi Liu, Hui Chen, Xiaomo Wu, et al.
International Journal of Surgery (London, England)|April 16, 2024
Development and comprehensive validation of a predictive prognosis model for very early HCC recurrence within one year after curative resection: a multicenter cohort studyLei Liu, Shangdong Qin, Kongying Lin, et al.
Proteomics. Clinical Applications|April 17, 2013
Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patientsYunbin Ye, Aimin Huang, Chuanzhong Huang, et al.
Frontiers in Oncology|March 8, 2021
Pre- and Postoperative Models for Prediction of Recurrence in Non-B, Non-C Hepatocellular CarcinomaKongying Lin, Qizhen Huang, Lei Wang, et al.
ILIVER|July 10, 2025
Tumor burden score and alpha-fetoprotein level predict prognosis of patients with unresectable hepatocellular carcinoma treated with tyrosine kinase inhibitor and anti-PD-1 antibodyShichuan Tang, Tingfeng Huang, Cong Luo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2025
Preoperative risk stratification for multifocal intrahepatic cholangiocarcinoma after liver resection: a multicenter analysis with CART modelJun Fu, Qizhu Lin, Lifang Zheng, et al.
Journal for Immunotherapy of Cancer|May 23, 2020
Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case reportYongyi Zeng, Wei Zhang, Zhenli Li, et al.
Data in Brief|November 7, 2015
Dataset for the quantitative proteomics analysis of the primary hepatocellular carcinoma with single and multiple lesionsXiaohua Xing, Yao Huang, Sen Wang, et al.
Nanoscale|January 12, 2021
Localized NIR-II photo-immunotherapy through the combination of photothermal ablation and <i>in situ</i> generated interleukin-12 cytokine for efficiently eliminating primary and abscopal tumorsXinyi Lin, Xiaoyan Wang, Jiong Li, et al.
Pageof 20